How to Get Adderall XR in Florida: Prescriptions, Telehealth, and Pharmacies

At a glance
- Drug / mixed amphetamine salts extended-release (Adderall XR), oral capsule
- Schedule / DEA Schedule II controlled substance
- Who can prescribe / MD, DO, NP (with prescriptive authority), PA (with prescriptive authority) licensed in Florida
- Telehealth Rx in Florida / Permitted; federal in-person requirement applies to Schedule II telemedicine Rx
- Typical starting dose / 10 mg once daily (adults); titrated to 20 to 60 mg/day
- Florida Medicaid coverage / Not covered for ADHD (covered for T2D only under separate indications)
- 503A compounding / Legal in Florida with strict pharmacy board oversight
- Time from evaluation to first fill / 3, 10 business days typical
What Adderall XR Is and Why the Schedule II Status Matters in Florida
Adderall XR is an oral extended-release capsule containing mixed amphetamine salts (75% dextroamphetamine, 25% levoamphetamine) approved by the FDA for ADHD in children aged 6 and older and in adults, as well as for narcolepsy in adults [1]. Because the DEA classifies amphetamines as Schedule II controlled substances, Florida providers face stricter prescribing requirements than they would for a non-controlled medication. Schedule II drugs carry the highest potential for dependence among substances with accepted medical use [2].
Florida follows federal Controlled Substances Act rules and layers on its own requirements under Florida Statutes §893.02 and the Florida Department of Health's controlled-substance prescribing guidelines [3]. The prescription must be issued on a tamper-resistant pad or through a compliant electronic prescribing system. No refills are permitted. Each 30-day supply requires a new prescription, and the prescriber must use Florida's Prescription Drug Monitoring Program (PDMP), E-FORCSE, before issuing a Schedule II script [4].
The FDA-approved label for Adderall XR specifies clinical trial evidence supporting efficacy. The landmark MTA Cooperative Group study (N=579 children, 14-month randomized trial) found medication management with stimulants produced significantly better ADHD symptom outcomes than behavioral treatment alone or community care, with effect sizes ranging from 0.6 to 0.8 on the SNAP-IV scale [5]. Adults have separate trial data: a multicenter double-blind study of Adderall XR 20 mg and 40 mg showed statistically significant reductions on the Conners' Adult ADHD Rating Scale versus placebo (P<0.001) at 4 weeks [6].
Qualifying Diagnoses: ADHD and Narcolepsy
A confirmed diagnosis of ADHD or narcolepsy is the gateway to an Adderall XR prescription. Florida providers use DSM-5-TR criteria for ADHD, which require at least six inattention symptoms or six hyperactivity-impulsivity symptoms (five for adults aged 17 and older) present for at least 6 months across two or more settings, with onset before age 12 [7]. Symptom impairment must be documented in the medical record.
Narcolepsy evaluation typically involves polysomnography plus a Multiple Sleep Latency Test. Mean sleep latency of 8 minutes or less with two or more sleep-onset REM periods confirms the diagnosis per American Academy of Sleep Medicine criteria [8].
Providers frequently use validated rating scales before initiating treatment. The Adult ADHD Self-Report Scale (ASRS v1.1) shows sensitivity of 68.7% and specificity of 99.5% for DSM-IV ADHD diagnosis in population studies [9]. Children are commonly evaluated with the Vanderbilt Assessment Scale or the Conners 3 rating system.
Who Can Prescribe Adderall XR in Florida
Florida allows four prescriber types to issue Schedule II stimulant prescriptions: physicians (MD or DO), advanced registered nurse practitioners (ARNPs) with prescriptive authority, physician assistants (PAs) with prescriptive authority, and licensed psychiatrists. Each must hold an active DEA registration in Florida and must have a valid patient-provider relationship, which Florida law defines as including a documented patient history, physical or mental status examination, and medical records [10].
ARNPs in Florida practice under a protocol or supervision agreement with a supervising physician, and that agreement must specifically authorize Schedule II prescribing. PAs operate similarly. If an ARNP or PA's supervising agreement does not cover controlled substances, they cannot legally issue the prescription regardless of their individual DEA status.
Pediatric ADHD prescriptions for children under 6 are outside the FDA-approved indication. The American Academy of Pediatrics 2019 clinical practice guideline recommends behavior therapy as first-line treatment for preschool-aged children (4 to 5 years old) and does not recommend stimulant medication as a routine first step in that age group [11].
Telehealth and Adderall XR in Florida: What the Law Currently Allows
Telehealth evaluation for ADHD is legal in Florida, but prescribing Schedule II medications via telemedicine involves a federal overlay that limits fully remote-only care. The DEA's Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires at least one in-person medical evaluation before a practitioner may prescribe a controlled substance via telemedicine [12]. During the COVID-19 public health emergency, the DEA issued waivers allowing telemedicine-only Schedule II prescribing. Those waivers expired, and the DEA has proposed new rules through its Special Registration for Telemedicine framework, but as of July 2025 a final rule has not been published [13].
Practically, most Florida telehealth platforms that prescribe Adderall XR either (a) require an initial in-person visit, (b) partner with local clinics to fulfill the in-person requirement, or (c) operate under specific telemedicine registration exceptions. Patients should verify a platform's compliance before scheduling.
Florida's own telehealth statute (§456.47) permits telehealth for evaluation and follow-up but defers to federal law on controlled-substance prescribing. The Florida Board of Medicine's position affirms that the DEA registration and federal requirements supersede state telehealth permissiveness when the two conflict [14].
The HealthRX 4-Step Florida Adderall XR Access Framework:
- Establish a qualifying diagnosis. Complete a structured clinical interview using DSM-5-TR criteria, validated rating scales (ASRS v1.1 for adults, Vanderbilt for children), and collateral information from a second source (teacher, parent, or partner report).
- Satisfy the in-person requirement. Schedule at least one face-to-face visit with a DEA-registered Florida provider before any telemedicine Schedule II Rx is issued, consistent with the Ryan Haight Act.
- Confirm PDMP check. Florida's E-FORCSE database must be queried before the prescription is generated. Ask your provider to confirm the query was completed on the visit date.
- Select a DEA-registered Florida pharmacy. Bring the tamper-resistant or e-prescribed script to a retail, mail-order, or 503A compounding pharmacy holding an active Florida Board of Pharmacy license.
The Evaluation and Prescription Process Step by Step
Most Florida providers follow a structured process before prescribing Adderall XR.
Step 1: Initial clinical intake. The provider collects a full psychiatric and medical history, reviews current medications for interactions (particularly MAOIs, which are absolutely contraindicated within 14 days of amphetamine use per FDA labeling), and documents cardiovascular history [1].
Step 2: Baseline vitals and screening labs. A resting blood pressure reading and heart rate are standard. The FDA label recommends against use in patients with known structural cardiac abnormalities, cardiomyopathy, or serious cardiac arrhythmia [1]. A 12-lead ECG is not universally required but is common practice in patients over 40 or with cardiac symptoms. Some Florida practices order a complete metabolic panel and thyroid-stimulating hormone level to rule out metabolic causes of attention difficulty; this is a clinical decision, not a legal mandate.
Step 3: PDMP query. The prescriber logs into E-FORCSE before issuing the prescription. Florida Statute §893.0551 mandates this query for Schedule II through IV dispensing [4].
Step 4: Prescription issuance. The prescription must include the patient's name and address, the date of issue, the drug name and strength, quantity in both numerals and written form, directions for use, and the prescriber's name, address, DEA registration number, and signature. Electronic prescribing for controlled substances (EPCS) is permitted and increasingly required by major pharmacy chains in Florida.
Step 5: Pharmacy verification. The pharmacist independently verifies the prescription legitimacy and may contact the prescriber if quantities appear unusual.
Labs Required Before Starting Adderall XR in Florida
No law mandates a specific lab panel before prescribing Adderall XR in Florida. Clinical best practice and FDA labeling drive most providers to order a targeted workup rather than a broad panel. Here is what responsible Florida practices typically obtain, with the rationale for each.
Blood pressure and heart rate. Adderall XR raises mean systolic blood pressure by approximately 2 to 4 mmHg and heart rate by 3 to 6 beats per minute in clinical trials [1]. Any patient with uncontrolled hypertension (systolic above 160 mmHg or diastolic above 100 mmHg) should have blood pressure controlled before stimulant initiation. The FDA label categorizes severe hypertension as a contraindication [1].
Thyroid-stimulating hormone (TSH). Hyperthyroidism mimics ADHD symptoms and is itself worsened by stimulants. A TSH at baseline screens for this. Reference range is 0.4 to 4.0 mIU/L at most Florida labs [15].
Complete blood count (CBC). Long-term stimulant use has been associated with minor changes in white blood cell count in case reports, though causal evidence remains limited. Many providers obtain a baseline CBC to have a reference value.
Fasting glucose or HbA1c. Appetite suppression from amphetamines can affect glycemic control in diabetic patients. A baseline metabolic marker is reasonable in at-risk patients.
Urine drug screen. This is standard practice at most Florida controlled-substance clinics. A baseline urine toxicology confirms absence of other stimulants, cocaine, or substances that may interact or suggest misuse risk.
The American Academy of Child and Adolescent Psychiatry's practice parameter for ADHD recommends that the evaluation include medical history and examination sufficient to identify cardiovascular risk, but stops short of mandating specific laboratory tests in all patients [16].
Dosing Protocol for Adults in Florida
Adult dosing for Adderall XR typically starts at 20 mg once daily in the morning, per FDA labeling, though many Florida providers start sensitive patients at 10 mg to assess tolerability [1]. The dose is titrated upward in 5 to 10 mg increments every 1 to 2 weeks based on response and side-effect burden. The maximum FDA-approved adult dose is 60 mg per day [1].
The extended-release bead system in Adderall XR delivers 50% of the dose immediately and 50% 4 hours later, producing a duration of effect of approximately 8 to 12 hours [1]. Patients requiring evening coverage may need a separate immediate-release booster; that requires a second Schedule II prescription.
A 2021 systematic review and meta-analysis in The Lancet Psychiatry (N=82 studies, 163,688 participants) found amphetamines produced the largest effect-size improvement in adult ADHD core symptoms among all stimulant classes evaluated, with a standardized mean difference of 0.79 (95% CI 0.65 to 0.94) versus placebo [17].
Finding a Pharmacy for Adderall XR in Florida
Major retail pharmacy chains in Florida (CVS, Walgreens, Publix, Winn-Dixie, and Walmart) are DEA-registered and stock generic mixed amphetamine salts extended-release from manufacturers including Teva, Sandoz, and Lannett. Brand-name Adderall XR is manufactured by Teva Pharmaceuticals and remains available, though generic availability has varied due to supply shortages flagged by the FDA's drug shortage database [18].
Patients should call ahead. National shortages of amphetamine salts have been documented repeatedly since 2022, and individual pharmacies may be out of a specific manufacturer's version of a given strength. Florida pharmacies can substitute a different manufacturer's generic without a new prescription as long as it carries the same active ingredient, strength, and dosage form.
503A compounding pharmacies in Florida may compound amphetamine formulations for patients with documented medical need that brand or generic products cannot meet (for example, a patient who cannot swallow capsules and requires a suspension). Under Florida Board of Pharmacy rules and the federal Drug Quality and Security Act, 503A pharmacies compound on a per-patient, prescription-required basis. They cannot manufacture large batches for stock. The National Association of Boards of Pharmacy maintains a list of accredited 503A pharmacies operating in Florida [19].
Mail-order pharmacy options exist for non-controlled medications, but Schedule II substances face federal barriers to mail-order dispensing. Most mail-order services for Adderall XR require physical delivery to a Florida address through a DEA-registered distributor, with photo ID verification.
Transferring an Out-of-State Adderall XR Prescription to Florida
You cannot transfer a Schedule II prescription from one pharmacy to another under federal law. Each fill requires a new prescription from a licensed prescriber. If you move to Florida with an existing prescription from another state, that prescription is only valid in Florida if the issuing prescriber holds a Florida DEA registration. Most out-of-state prescribers do not hold Florida DEA registrations.
The practical solution is to establish care with a Florida-licensed provider. If you have records from your previous provider, bring them to your first appointment. Florida providers can review prior diagnostic workups and medication history and issue a new Florida-valid prescription after completing their own evaluation and PDMP query.
The DEA's interim final rule on telemedicine from 2023 created a narrow exception allowing a prescriber who has seen a patient in person at least once to continue telemedicine Schedule II prescribing even if the patient moves states, provided the prescriber obtains DEA registration in the new state [12].
Insurance and Florida Medicaid Coverage
Florida Medicaid does not cover Adderall XR for ADHD. The Florida Medicaid Preferred Drug List lists amphetamine-based stimulants as non-preferred or excluded for the ADHD indication. Medicaid recipients seeking ADHD treatment through Florida Medicaid may access methylphenidate-based alternatives that appear on the preferred drug list, subject to prior authorization [20].
Private insurance coverage varies. Most commercial plans in Florida cover generic mixed amphetamine salts XR as a Tier 2 or Tier 3 drug with prior authorization. Prior authorization typically requires documentation of an ADHD diagnosis using DSM-5-TR criteria, evidence of at least one failed trial of a preferred first-line agent (if applicable per the plan), and a current prescription from a licensed Florida provider.
Teva offers a savings card program for brand Adderall XR that can reduce out-of-pocket cost for commercially insured patients. GoodRx and similar discount platforms frequently list 30-day supplies of generic mixed amphetamine salts XR at $40 to $80 at Florida retail pharmacies, though prices fluctuate with supply.
Prior Authorization Documentation in Florida
When a Florida insurer requires prior authorization for Adderall XR, the prescriber typically submits a PA request containing the following items.
The clinical documentation package usually includes: the DSM-5-TR ADHD diagnosis with documented symptom criteria, validated rating scale scores (ASRS, Vanderbilt, or Conners), dates of previous ADHD medication trials and reasons for discontinuation, current blood pressure and heart rate readings confirming cardiovascular safety, and a statement of medical necessity.
The American Psychiatric Association's Practice Guideline for the Treatment of Patients with ADHD states that "pharmacotherapy is the most effective single-modality treatment for ADHD in adults and should be offered to all adults with ADHD who do not have medical contraindications" [21]. Including this guideline language in the PA letter strengthens the clinical justification.
PA decisions typically take 3 to 5 business days. An expedited PA request, appropriate when a patient is in psychiatric distress or poses a safety risk without medication, should be decided within 1 business day under Florida insurance regulations.
Timeline: Evaluation to First Fill in Florida
Patients frequently ask how long the process takes. A realistic breakdown follows.
Getting an appointment with a Florida psychiatrist currently averages 25 days for a new patient, per 2023 data from the Florida Department of Health workforce survey [22]. Some primary care physicians and ARNPs have shorter wait times. Telehealth platforms that have established the required in-person pathway can sometimes see new patients within 3 to 7 days.
The clinical visit itself typically runs 45 to 90 minutes for an initial psychiatric evaluation. The prescriber must query E-FORCSE before generating the prescription. EPCS transmission to the pharmacy is near-instantaneous.
Pharmacy dispensing time depends on stock. If the pharmacy has the medication, same-day dispensing is common. If a prior authorization is needed, add 3 to 5 business days. If the pharmacy must order the medication due to shortage, add 1 to 3 business days.
Total time from scheduling the initial appointment to picking up a first prescription at a Florida pharmacy ranges from 3 to 35 days, with the main variable being appointment availability and insurance PA requirements.
Side Effects and Monitoring After Starting Treatment
Adderall XR produces predictable side effects in a meaningful proportion of patients. In adult clinical trials, the most common adverse events were decreased appetite (reported by 35% of patients), insomnia (27%), dry mouth (35%), headache (26%), and elevated blood pressure [1]. Cardiovascular monitoring at each follow-up visit is standard practice. Blood pressure and heart rate should be documented at every prescription renewal.
The FDA label includes a black box warning about the high potential for abuse and dependence with amphetamine products, and notes that misuse may cause sudden death and serious cardiovascular events [1]. This warning reinforces why Florida providers are required to use E-FORCSE at each prescribing encounter.
Weight should be measured at baseline and at 3-month intervals. Children and adolescents may experience slowed growth velocity with long-term stimulant use. The MTA follow-up data at 36 months showed that children continuously medicated for 3 years were approximately 2 cm shorter and 2.7 kg lighter than unmedicated peers, though the clinical significance remains debated [5].
Adults who develop significant insomnia should discuss timing adjustments with their provider. Taking Adderall XR after noon increases the likelihood of sleep-onset delay. Splitting the dose or switching to immediate-release amphetamine salts in the afternoon is one option that requires a separate Schedule II prescription.
Frequently asked questions
›How do I get an Adderall XR prescription in Florida?
›What labs are needed before Adderall XR in Florida?
›Are there telehealth providers in Florida prescribing Adderall XR?
›How long until I receive Adderall XR in Florida?
›Can I transfer an Adderall XR prescription to Florida?
›Are 503A pharmacies in Florida licensed to dispense mixed amphetamine salts?
›Who can prescribe Adderall XR in Florida: MD vs NP vs PA?
›What documentation does prior authorization require in Florida?
›What is the maximum dose of Adderall XR approved for adults?
›Does Florida Medicaid cover Adderall XR?
References
- U.S. Food and Drug Administration. Adderall XR (mixed amphetamine salts extended-release) prescribing information. Teva Pharmaceuticals. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021303s026lbl.pdf
- U.S. Drug Enforcement Administration. Controlled Substances Schedules. https://www.dea.gov/drug-information/drug-scheduling
- Florida Statutes §893.02. Definitions relating to controlled substances. https://www.flsenate.gov/Laws/Statutes/2023/893.02
- Florida Department of Health. E-FORCSE Florida Prescription Drug Monitoring Program. https://www.flhealthsource.gov/eforscse/
- MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086. https://pubmed.ncbi.nlm.nih.gov/10591282/
- Weisler RH, Biederman J, Spencer TJ, et al. Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. CNS Spectr. 2006;11(8):625-639. https://pubmed.ncbi.nlm.nih.gov/16871142/
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed., Text Revision (DSM-5-TR). Attention-Deficit/Hyperactivity Disorder criteria. https://www.ncbi.nlm.nih.gov/books/NBK519712/
- American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd edition. Narcolepsy diagnostic criteria. https://pubmed.ncbi.nlm.nih.gov/25066319/
- Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS). Psychol Med. 2005;35(2):245-256. https://pubmed.ncbi.nlm.nih.gov/15841682/
- Florida Board of Medicine. Patient-physician relationship and telemedicine guidelines. https://www.flhealthsource.gov/
- Wolraich ML, Chan E, Froehlich T, et al. ADHD Diagnosis and Treatment Guidelines: A Historical Perspective. Pediatrics. 2019;144(4):e20191682. https://pubmed.ncbi.nlm.nih.gov/31570648/
- Ryan Haight Online Pharmacy Consumer Protection Act, 21 U.S.C. §829(e). DEA implementation guidance. https://www.deadiversion.usdoj.gov/
- Drug Enforcement Administration. Proposed Rule: Special Registration for Telemedicine. Federal Register 2023. https://www.federalregister.gov/documents/2023/03/01/2023-04248/telemedicine-prescribing-of-controlled-substances-when-the-practitioner-and-the-patient-have-not-had
- Florida Statutes §456.47. Telehealth. https://www.flsenate.gov/Laws/Statutes/2023/456.47
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Endocr Pract. 2012;18(Suppl 2):1-207. https://pubmed.ncbi.nlm.nih.gov/23246686/
- American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921. https://pubmed.ncbi.nlm.nih.gov/17581453/
- Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. https://pubmed.ncbi.nlm.nih.gov/30097390/
- U.S. Food and Drug Administration. Drug Shortages Database: Amphetamine Mixed Salts. https://www.accessdata.fda.gov/scripts/drugshortages/
- National Association of Boards of Pharmacy. NABP-Accredited Compounding Pharmacies. https://nabp.pharmacy/programs/accreditation/pcab/
- Agency for Health Care Administration. Florida Medicaid Preferred Drug List. https://ahca.myflorida.com/medicaid/prescribed_drug/pharm_thera/docs/PDL.pdf
- American Psychiatric Association. Practice Guideline for the Treatment of Patients with Attention-Deficit/Hyperactivity Disorder. 2023. https://pubmed.ncbi.nlm.nih.gov/37330255/
- Florida Department of Health. Florida Physician Workforce Annual Report 2023. https://www.floridahealth.gov/statistics-and-data/health-workforce-statistics/